Calendar

pharmadog

Week of Jun 20, 2022

Jun 22, 2022approval1533d agoMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalSpexotras

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →Spexotras →fda approvals ↗

Jun 22, 2022approval1533d agoTAFINLAR (DABRAFENIB MESYLATE) — FDA approvaldabrafenib mesylate ODT

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

full page →dabrafenib mesylate ODT →fda approvals ↗

Jun 22, 2022approval1533d agoVIGABATRIN — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jun 23, 2022approval1532d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Jun 23, 2022approval1532d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: AUROBINDO PHARMA. Form: SOLUTION. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Jun 23, 2022approval1532d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: AUROBINDO PHARMA. Form: SOLUTION. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Jun 23, 2022approval1532d agoRELEXXII (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: OSMOTICA PHARM US. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jun 24, 2022approval1531d agoVIGPODER (VIGABATRIN) — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: PYROS PHARMS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Jun 24, 2022approval1531d agoQSYMIA (PHENTERMINE HYDROCHLORIDE) — FDA approval(phentermine hydrochloride + topiramate) ER

Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →(phentermine hydrochloride + topiramate) ER →fda approvals ↗

Jun 24, 2022approval1531d agoVEKLURY (REMDESIVIR) — FDA approvalremdesivir

Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS

full page →remdesivir →fda approvals ↗

Week of Jun 27, 2022

Jun 28, 2022approval1527d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

full page →tramadol hydrochloride ER →fda approvals ↗

Jun 30, 2022approval

Week of Jul 4, 2022

Jul 6, 2022approval1519d agoVALPROIC ACID — FDA approvalCereno Scientific AB

Sponsor: HIBROW HLTHCARE. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jul 6, 2022approval

Week of Jul 11, 2022

Jul 12, 2022approval1513d agoGAZYVA (OBINUTUZUMAB) — FDA approvalobinutuzumab

Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION

full page →obinutuzumab →fda approvals ↗

Jul 13, 2022approval

Week of Jul 18, 2022

Jul 18, 2022approval1507d agoHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalHYRIMOZ

Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

full page →HYRIMOZ →fda approvals ↗

Jul 18, 2022approval

Week of Jul 25, 2022

Jul 26, 2022approval1499d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Jul 27, 2022approval

← prev

page 263 of 621

Week of Jun 20, 2022

Week of Jun 27, 2022

Week of Jul 4, 2022

Week of Jul 11, 2022

Week of Jul 18, 2022

Week of Jul 25, 2022